Loading...
NPI 1578521266 · Fountain Valley, CA · Hematology & Oncology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Lalita Pandit is a hematology & oncology physician provider located in Fountain Valley, California. This profile covers 38 Medicare and 25 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Lalita Pandit |
| Address | 11180 Warner Ave |
| City | Fountain Valley |
| State | CA |
| ZIP | 92708 |
| Taxonomy | Hematology & Oncology Physician |
| NPI Enumerated | May 2, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $720.8K |
| Medicare | $542.4K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
38 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,430 | $100 | $145.7K |
| J0897 | Injection, denosumab, 1 mg | 4,740 | $20 | $85.3K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 660 | $90 | $58.7K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 7,170 | $10 | $43K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 280 | $120 | $33.7K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 140 | $130 | $18.6K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 150 | $100 | $15K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 220 | $60 | $12.9K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 1,490 | $10 | $11.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 70 | $150 | $11.1K |
Showing 1–10 of 38
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 38 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
38 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0897 | 352 | 1,030 | 3,060 | $20 | $91.4K |
| Q5122 | 3 | 10 | 550 | $90 | $72.5K |
| 96413 | 182 | 620 | 170 | $120 | $26.9K |
| 99233 | 5,037 | 11,530 | 120 | $100 | $26.2K |
| Q5106 | 10 | 70 | 3,230 | $10 | $23.7K |
| 99214 | 697 | 37,970 | 120 | $90 | $23.2K |
| J9217 | 149 | 320 | 130 | $130 | $22.1K |
| 85025 | 171 | 1,210 | 150 | $10 | $17.2K |
| 99215 | 5,803 | 15,360 | 50 | $130 | $14.4K |
| 99213 | 28,463 | 34,660 | 80 | $70 | $13.2K |
Showing 1–10 of 38
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
25 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 9,060 | $30 | $280.9K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 1,670 | $40 | $64.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 2,190 | $20 | $50.4K |
| 99211 | An established patient presents for an office or other outpatient visit that may not require the presence of a physician or other qualified healthcare professional. | 3,820 | $10 | $49.7K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 1,590 | $30 | $41.4K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 2,690 | $10 | $32.3K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 650 | $40 | $23.4K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 600 | $40 | $23.2K |
| 96360 | The provider introduces a catheter intravenously for supplementation of fluid and electrolytes for 31 minutes to one hour to treat severe cases of dehydration. | 570 | $40 | $23K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 460 | $50 | $22.7K |
Showing 1–10 of 25
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
25 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 311 | 500 | 3,580 | $40 | $230.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 357 | 520 | 1,470 | $70 | $193.2K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 1,290 | 2,670 | 540 | $40 | $183.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,426 | 13,300 | 640 | $40 | $169.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 89 | 320 | 610 | $60 | $162.5K |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 306 | 450 | 2,790 | $30 | $142.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 7,615 | 14,520 | 760 | $10 | $122.8K |
| 96360 | The provider introduces a catheter intravenously for supplementation of fluid and electrolytes for 31 minutes to one hour to treat severe cases of dehydration. | 251 | 400 | 1,130 | $50 | $100.6K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 1,951 | 2,730 | 190 | $90 | $100.3K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 699 | 2,100 | 1,130 | $1 | $83.5K |
Showing 1–10 of 25
Other providers in the same ZIP code as Lalita Pandit, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Lab Genomics, LLC | CA | Clinical Medical Laboratory | $292.5K | $11M |
| Chih-tao Hou | CA | Family Nurse Practitioner | $3.8M | $0 |
| Chiwai Chan | CA | Interventional Pain Medicine Physician | $857.1K | $2.3M |
| Orange County Diagnostic Radiology, Inc. | CA | Specialist | $1.2M | $1.6M |
| Tien Nguyen | CA | Dermatology Physician | $447.5K | $2.2M |
| Abdulkareem Sharaf | CA | Cardiovascular Disease Physician | $1.2M | $1.2M |
| Son Duong | CA | Vascular Surgery Physician | $1.2M | $1.1M |
| Steven Le | CA | Cardiovascular Disease Physician | $1.2M | $584.3K |
| Medizen Advanced Imaging Inc | CA | Diagnostic Ultrasound Physician | $465.2K | $1.3M |
| Harpreet Singh | CA | Specialist | $903.2K | $728.8K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.